TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18085911

Group type: EXPERIMENTAL
Intervention: Day hospital (n=154)
Number of subjects: 694

Group type: COMPARATOR
Intervention: Community residential treatment (n=139)
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: Self-selected day hospital (n=321)
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: Directed residential treatment (n=82)
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: Index treatment days and 12-step attendance
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: Gender and ethnicity
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: 12-step attendance
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: Treatment beyond the index stay
Number of subjects: 694
Study: 15351750

Group type: EXPERIMENTAL
Intervention: Information prescription (IP) with computer training and training summary handout
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Information prescription (IP) users
Number of subjects: 197

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 197
Study: 11781675

Group type: EXPERIMENTAL
Intervention: Sterol esters (2.4 g)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Stanols (2.4 g)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Dairy spread (control)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Sitosterol ester fortified spread (2.4 g)
Number of subjects: 37
Study: 9476087

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (0.05 mg/day) and norethisterone acetate orally (2.5 mg/day) for 12 days every 2 months (group A)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (0.05 mg/day) and norethisterone acetate orally (2.5 mg/day) for 12 days every 3 months (group B)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 172
Study: 7943861

Group type: EXPERIMENTAL
Intervention: Intraoperative autohemotransfusion
Number of subjects: 0
Study: 3928264

Group type: EXPERIMENTAL
Intervention: 200 mg ketoprofen
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1.8 g lysine acetylsalicylate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 30165472

Group type: EXPERIMENTAL
Intervention: Adequate intake of vitamin E
Number of subjects: 1002
Study: 29555857

Group type: EXPERIMENTAL
Intervention: LSD (100 μg, p.o.)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ketanserin (40 mg, p.o.) + LSD (100 μg, p.o.)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo + LSD (100 μg, p.o.)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo + Placebo
Number of subjects: 24
Study: 27913408

Group type: EXPERIMENTAL
Intervention: d-serine administration
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 40
Study: 24346808

Group type: EXPERIMENTAL
Intervention: Baclofen (10 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dimenhydrinate (40 mg) plus Cinnarizine (25 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meclizine (25 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Promethazine (25 mg) plus D-Amphetamine (10 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23720216

Group type: EXPERIMENTAL
Intervention: Cisplatin-based chemotherapy
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Nomogram based on pretreatment variables
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Nomogram predictions
Number of subjects: 399
Study: 20500134

Group type: EXPERIMENTAL
Intervention: Therapeutic ultrasound for 4 consecutive days
Number of subjects: 48

Group type: COMPARATOR
Intervention: Antibiotics (amoxicillin) for a 10-day course
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Therapeutic ultrasound
Number of subjects: 48

Group type: COMPARATOR
Intervention: Antibiotics (amoxicillin)
Number of subjects: 48
Study: 18381313

Group type: EXPERIMENTAL
Intervention: Hamstring tendon autograft
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bone‐patellar tendon‐bone autograft
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 16618011

Group type: EXPERIMENTAL
Intervention: Metformin (850 to 1700 mg daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 14560412

Group type: EXPERIMENTAL
Intervention: Highly cross-linked polyethylene (Crossfire; Stryker Howmedica Osteonics)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard polyethylene (N(2)/Vac, Stryker Howmedica Osteonics)
Number of subjects: 46
Study: 10780766

Group type: EXPERIMENTAL
Intervention: Inhaled flunisolide (500 microg b.i.d)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 8833892

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 1361250

Group type: EXPERIMENTAL
Intervention: Salmeterol (50 micrograms)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 7004560

Group type: EXPERIMENTAL
Intervention: Single agent chlorambucil
Number of subjects: 47

Group type: COMPARATOR
Intervention: Five-drug combination (chlorambucil, methotrexate, fluorouracil, vincristine, adriamycin)
Number of subjects: 47
Study: 30730274

Group type: EXPERIMENTAL
Intervention: Birch pollen allergoid subcutaneous immunotherapy (4 weekly injections)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Birch pollen allergoid subcutaneous immunotherapy (7 weekly injections)
Number of subjects: 130
Study: 28073844

Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg intravenously every 2 weeks
Number of subjects: 418

Group type: COMPARATOR
Intervention: Dacarbazine 1,000 mg/m2 intravenously every 3 weeks
Number of subjects: 418
Study: 26060154

Group type: EXPERIMENTAL
Intervention: Massage therapy (20 minutes, twice a day for four days)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (routine therapy only)
Number of subjects: 40
Study: 23371747

Group type: EXPERIMENTAL
Intervention: Group O (opposite change for eyes and hand)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Group S (same change for eyes and hand)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Group E (eyes-only adaptation)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Group H (hand-only adaptation)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Group ON (no visual feedback of the hand)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Overall adaptation
Number of subjects: 40
Study: 21330484

Group type: EXPERIMENTAL
Intervention: Ultrafiltration
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control
Number of subjects: 150
Study: 20037100

Group type: EXPERIMENTAL
Intervention: pi-circuit technique (off-pump coronary artery bypass, aorta no-touch technique)
Number of subjects: 200
Study: 17551378

Group type: EXPERIMENTAL
Intervention: Periodontal treatment consisting of scaling/root planing and oral hygiene instruction
Number of subjects: 29

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Periodontal treatment
Number of subjects: 29
Study: 17142410

Group type: EXPERIMENTAL
Intervention: Continuous infusion of 0.5% bupivacaine into the iliac crest harvest site
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups received morphine sulfate via patient-controlled analgesia pump
Number of subjects: 60
Study: 14512038

Group type: EXPERIMENTAL
Intervention: Nutritional supplements (352 kcal/day)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Usual hospital nutrition
Number of subjects: 109
Study: 10658936

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (8 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: N(G)-monomethyl-L-arginine (L-NMMA; 3 mg/kg) after CsA
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: N(G)-monomethyl-L-arginine (L-NMMA)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control day (without CsA)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (8 mg/kg) followed by L-NMMA
Number of subjects: 10
Study: 7551612

Group type: COMPARATOR
Intervention: Daily live self-exposure and ritual prevention to external cues (Ex)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Daily self-exposure to imagined internal cues of the consequences of not ritualising (Exi)
Number of subjects: 46
Study: 2042792

Group type: EXPERIMENTAL
Intervention: 20 mg nifedipine
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 20 mg nicardipine
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 25 mg captopril
Number of subjects: 65
Study: 7233310

Group type: EXPERIMENTAL
Intervention: Family Health Project (FHP) group
Number of subjects: 2

Group type: COMPARATOR
Intervention: Community Care (CC) group
Number of subjects: 2
Study: 31619393

Group type: EXPERIMENTAL
Intervention: Active TWO2 therapy
Number of subjects: 220

Group type: COMPARATOR
Intervention: Sham control therapy
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Active TWO2 therapy (after adjustment for UTC grade)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Sham control therapy (after adjustment for UTC grade)
Number of subjects: 220
Study: 29978261

Group type: EXPERIMENTAL
Intervention: Active TENS
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 46
Study: 26976971

Group type: EXPERIMENTAL
Intervention: S-1 (oral fluoropyrimidine)
Number of subjects: 795
Study: 25572482

Group type: EXPERIMENTAL
Intervention: 1 Hz, 110% MT, 420 stimuli/day
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 1 Hz, 110% MT, 900 stimuli/day
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 10 Hz, 80% MT, 750 stimuli/day
Number of subjects: 33
Study: 23244367

Group type: EXPERIMENTAL
Intervention: Trauma writing intervention (4 sessions of 30 minutes each)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Daily events writing (attention control)
Number of subjects: 244
Study: 20940567

Group type: EXPERIMENTAL
Intervention: PSP clinical pathway applied to treatment group (n = 30)
Number of subjects: 60
Study: 18060441

Group type: EXPERIMENTAL
Intervention: ramelteon 16 mg
Number of subjects: 26

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 26
Study: 15929507

Group type: EXPERIMENTAL
Intervention: Training on the critical appraisal of published research papers and practice guidelines (Strategy A)
Number of subjects: 1470

Group type: EXPERIMENTAL
Intervention: Training on the critical appraisal of published research papers and practice guidelines plus training on management of change in clinical practice (Strategy B)
Number of subjects: 1470

Group type: COMPARATOR
Intervention: Strategy A
Number of subjects: 1470

Group type: COMPARATOR
Intervention: Strategy B
Number of subjects: 1470
Study: 12912787

Group type: EXPERIMENTAL
Intervention: Perceived time constraints
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Perceived support for physical activity
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Self-worth scale
Number of subjects: 201
Study: 10587552

Group type: EXPERIMENTAL
Intervention: Hormonal Replacement Therapy (HRT) - conjugated oestrogen 0.625 mg daily from day 1 to day 21 plus medroxyprogesterone acetate 5 mg daily days 10-21
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Calcitriol - 0.5 microg daily
Number of subjects: 28

Group type: COMPARATOR
Intervention: Comparison of HRT and Calcitriol
Number of subjects: 28
Study: 8600863

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control
Number of subjects: 112
Study: 1938979

Group type: EXPERIMENTAL
Intervention: Maprotiline 75 mg, 1 tablet
Number of subjects: 1141

Group type: EXPERIMENTAL
Intervention: Maprotiline 75 mg, 1/2 tablet
Number of subjects: 1141

Group type: COMPARATOR
Intervention: Placebo, 1 tablet
Number of subjects: 1141

Group type: COMPARATOR
Intervention: Placebo, 1/2 tablet
Number of subjects: 1141
Study: 7148967

Group type: EXPERIMENTAL
Intervention: Dorsal resting hand splints
Number of subjects: 10

Group type: COMPARATOR
Intervention: Volar resting hand splints
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Older subjects (both groups)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Younger subjects (both groups)
Number of subjects: 10
Study: 30830179

Group type: EXPERIMENTAL
Intervention: Testosterone treatment
Number of subjects: 657

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 657
Study: 28067086

Group type: EXPERIMENTAL
Intervention: Prophylactic dose of 2000 mg of amoxicillin clavulanate, continued with amoxicillin clavulanate postoperatively
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Prophylactic dose of 600 mg of clindamycin, continued with clindamycin postoperatively
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Prophylactic chlorhexidin rinsing, continued randomized amoxicillin clavulanate or clindamycin postoperatively
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group with clindamycin postoperatively
Number of subjects: 71
Study: 25725179

Group type: EXPERIMENTAL
Intervention: Continuous low-dose methylprednisolone infusion (1mg/kg loading dose followed by 2mg/Kg/24 hours for 1 day)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Single high-dose methylprednisolone (15 mg/kg before cardiopulmonary bypass)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Continuous low-dose methylprednisolone infusion
Number of subjects: 72

Group type: COMPARATOR
Intervention: Single high-dose methylprednisolone
Number of subjects: 72
Study: 23911008

Group type: EXPERIMENTAL
Intervention: Voice training exercises and vocal hygiene education (5 sessions total, including 4 vocal exercise sessions)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group with vocal hygiene education (2 sessions)
Number of subjects: 102
Study: 21220404

Group type: EXPERIMENTAL
Intervention: High optimism quartile
Number of subjects: 5634

Group type: COMPARATOR
Intervention: Lowest optimism category
Number of subjects: 5634
Study: 19190213

Group type: EXPERIMENTAL
Intervention: Chlorproguanil-dapsone (CD)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Sulfadoxine-pyrimethamine plus Chloroquine (SP + CQ)
Number of subjects: 264
Study: 17728962

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (RAZA Pharmaniaga, Malaysia)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ciprobay (Bayer AG, Germany)
Number of subjects: 24
Study: 15142155

Group type: EXPERIMENTAL
Intervention: lidocaine‐prilocaine solution
Number of subjects: 42

Group type: COMPARATOR
Intervention: inert cream
Number of subjects: 42
Study: 11300448

Group type: EXPERIMENTAL
Intervention: 2 mg oral estradiol for three months
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo for three months
Number of subjects: 19
Study: 9339168

Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 74

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 74
Study: 8288374

Group type: EXPERIMENTAL
Intervention: Low pin placement between the anterior iliac spines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional pin placement at the superior iliac crest
Number of subjects: 0
Study: 3524548

Group type: EXPERIMENTAL
Intervention: Intravenous labetalol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous diazoxide
Number of subjects: 0
Study: 30396557

Group type: EXPERIMENTAL
Intervention: Etonogestrel (ENG) implant
Number of subjects: 103

Group type: COMPARATOR
Intervention: Levonorgestrel-releasing intrauterine system (LNG-IUS)
Number of subjects: 103
Study: 26740682

Group type: EXPERIMENTAL
Intervention: Multiple-micronutrient supplement (MMN) providing 18 micronutrients including 800 μg retinol equivalents of vitamin A
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplement (LNS) with the same nutrients as MMN plus 4 minerals and macronutrients
Number of subjects: 1320

Group type: COMPARATOR
Intervention: Iron and folic acid (control group) during pregnancy and placebo (calcium tablet) during the first 6 months postpartum
Number of subjects: 1320
Study: 24158593

Group type: EXPERIMENTAL
Intervention: Fosdevirine 100 mg
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Fosdevirine 200 mg
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (Etravirine 200 mg twice daily)
Number of subjects: 35
Study: 23082409

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral program
Number of subjects: 540

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 540
Study: 19195912

Group type: EXPERIMENTAL
Intervention: Gabapentin therapy
Number of subjects: 30
Study: 18487271

Group type: EXPERIMENTAL
Intervention: Informed consent information recall
Number of subjects: 82
Study: 16162986

Group type: EXPERIMENTAL
Intervention: WIPSS Brain‐Pad mouth guard
Number of subjects: 646

Group type: COMPARATOR
Intervention: Standard use mouth guard of choice
Number of subjects: 646
Study: 14700098

Group type: EXPERIMENTAL
Intervention: BSS with antibiotics (vancomycin and gentamycin)
Number of subjects: 640

Group type: COMPARATOR
Intervention: BSS-only
Number of subjects: 640
Study: 11568134

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg/kg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 9368818

Group type: EXPERIMENTAL
Intervention: Learner centred group
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Expert group
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 66
Study: 1555950

Group type: COMPARATOR
Intervention: External beam irradiation to a dose of 2000 cGy delivered in 10 fractions over 2 weeks (Group A)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High dose rate intracavitary irradiation to a dose of 1200 cGy delivered in two sessions of 600 cGy each a week apart (Group B)
Number of subjects: 50
Study: 3927960

Group type: EXPERIMENTAL
Intervention: Nicardipine (5 mg h-1 for 3 h)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 30614860

Group type: EXPERIMENTAL
Intervention: His bundle pacing (HBP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Left bundle branch pacing (LBBP)
Number of subjects: 0
Study: 27306581

Group type: EXPERIMENTAL
Intervention: Flunarizine 10 mg/d
Number of subjects: 62

Group type: COMPARATOR
Intervention: Topiramate 50 mg/d
Number of subjects: 62
Study: 26421929

Group type: EXPERIMENTAL
Intervention: Videoconferencing-based psychoeducational group intervention
Number of subjects: 117

Group type: COMPARATOR
Intervention: Conventional postsurgical visits
Number of subjects: 117
Study: 23522992

Group type: EXPERIMENTAL
Intervention: Asmofilcon A lens
Number of subjects: 47

Group type: COMPARATOR
Intervention: Lotrafilcon B lens
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both lenses
Number of subjects: 47
Study: 21670942

Group type: EXPERIMENTAL
Intervention: Friskis&Svettis® Open Doors programme (60-minute comprehensive group-training programme, twice a week for 14 weeks)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 35
Study: 19734595

Group type: EXPERIMENTAL
Intervention: Celecoxib 400 mg from POD0 to POD5 and 200 mg until POD14 plus IV PCA (fentanyl 1.0 mg/100 mL) postoperatively
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo plus IV PCA postoperatively
Number of subjects: 60
Study: 16724990

Group type: EXPERIMENTAL
Intervention: HAI alternating with systemic chemotherapy (HA + SC group)
Number of subjects: 29

Group type: COMPARATOR
Intervention: HR + SC group (control)
Number of subjects: 29
Study: 15541082

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (ASC)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Acetic acid (ACA)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Sodium hydroxide (NaOH)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulphate (SLS) with ASC or ACA
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Sodium hydroxide (NaOH) with SLS
Number of subjects: 19
Study: 11329230

Group type: EXPERIMENTAL
Intervention: Strict avoidance of hypoglycemia
Number of subjects: 10
Study: 9559492

Group type: EXPERIMENTAL
Intervention: 5‐fluorouracil (5‐FU) (50.0 mg/ml for 5 minutes)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: mitomycin C (MMC) (0.5 mg/ml for 3.5 minutes)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Overall (both groups)
Number of subjects: 101
Study: 7871085

Group type: EXPERIMENTAL
Intervention: Scopolamine (0.3, 0.6 mg IM)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Lorazepam (2 mg oral)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Scopolamine and Lorazepam (active treatments)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 36
Study: 3281516

Group type: EXPERIMENTAL
Intervention: Naftidrofuryl (400 mg, two times daily for eight weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (two identical tablets daily for eight weeks)
Number of subjects: 40
Study: 1851680

Group type: EXPERIMENTAL
Intervention: Wrist cuff at supra-systolic pressure
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Wrist cuff at supra-venous pressure
Number of subjects: 11
Study: 1138025

Group type: EXPERIMENTAL
Intervention: L-methionine supplementation at 0.58 g/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L-methionine supplementation at 1.16 g/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DL-methionine supplementation at 0.58 g/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DL-methionine supplementation at 1.16 g/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: D-methionine supplementation at 0.58 g/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: D-methionine supplementation at 1.16 g/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unsupplemented diet (control)
Number of subjects: 0
Study: 31752836

Group type: EXPERIMENTAL
Intervention: 0.15% Guava mouth rinse
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.2% Chlorhexidine (CHX) mouth rinse
Number of subjects: 60

Group type: COMPARATOR
Intervention: Distilled water (placebo)
Number of subjects: 60
Study: 28686006

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Health Education
Number of subjects: 86
Study: 26011787

Group type: EXPERIMENTAL
Intervention: Dexketoprofen (0.25 mg/kg)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Racemic Ketoprofen (0.5 mg/kg)
Number of subjects: 221